Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,167 | 452 | 100.0% |
| Education | $2.69 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,667 | 72 | $0 (2024) |
| Novo Nordisk Inc | $925.20 | 82 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $662.13 | 63 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $411.69 | 27 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $407.32 | 24 | $0 (2024) |
| Abbott Laboratories | $242.68 | 14 | $0 (2024) |
| Merck Sharp & Dohme LLC | $232.04 | 9 | $0 (2023) |
| GlaxoSmithKline, LLC. | $230.96 | 13 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $227.25 | 15 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $214.31 | 13 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,324 | 74 | Novo Nordisk Inc ($298.54) |
| 2023 | $1,399 | 80 | AstraZeneca Pharmaceuticals LP ($166.65) |
| 2022 | $895.70 | 58 | AstraZeneca Pharmaceuticals LP ($222.68) |
| 2021 | $893.17 | 61 | AstraZeneca Pharmaceuticals LP ($239.62) |
| 2020 | $573.96 | 35 | AstraZeneca Pharmaceuticals LP ($213.07) |
| 2019 | $786.48 | 53 | AstraZeneca Pharmaceuticals LP ($250.61) |
| 2018 | $840.90 | 61 | AstraZeneca Pharmaceuticals LP ($212.37) |
| 2017 | $456.14 | 31 | AstraZeneca Pharmaceuticals LP ($134.82) |
All Payment Transactions
453 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: DIABETES | ||||||
| 12/11/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $20.49 | General |
| Category: Obesity | ||||||
| 12/09/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $12.67 | General |
| Category: Obesity | ||||||
| 12/09/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $2.67 | General |
| Category: Obesity | ||||||
| 12/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $2.66 | General |
| Category: Diabetes | ||||||
| 12/04/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $8.36 | General |
| Category: Diabetes | ||||||
| 12/04/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $6.00 | General |
| Category: Diabetes | ||||||
| 11/15/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.01 | General |
| Category: Diabetes | ||||||
| 11/08/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: Cardio-renal | ||||||
| 11/08/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: Diabetes | ||||||
| 11/06/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $20.78 | General |
| Category: Biological | ||||||
| 11/06/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $7.02 | General |
| Category: Diabetes | ||||||
| 10/31/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $20.86 | General |
| Category: Oncology | ||||||
| 10/31/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $2.79 | General |
| Category: Diabetes | ||||||
| 10/21/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $12.48 | General |
| Category: Cardio-renal | ||||||
| 10/20/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: Diabetes | ||||||
| 10/10/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $23.35 | General |
| Category: RESPIRATORY | ||||||
| 10/09/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $6.74 | General |
| Category: Diabetes | ||||||
| 09/26/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $19.54 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/18/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $17.78 | General |
| Category: Cardiovascular | ||||||
| 09/13/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $29.00 | General |
| Category: Endocrinology | ||||||
| 09/04/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.59 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/29/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.73 | General |
| Category: Inflammation | ||||||
| 08/28/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $20.68 | General |
| Category: UROLOGY | ||||||
| 08/28/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $10.40 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 569 | 991 | $134,407 | $64,469 |
| 2022 | 12 | 522 | 1,037 | $138,164 | $64,562 |
| 2021 | 12 | 668 | 1,358 | $169,637 | $82,854 |
| 2020 | 14 | 694 | 1,404 | $186,862 | $83,173 |
All Medicare Procedures & Services
51 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 110 | 258 | $47,730 | $20,207 | 42.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 78 | 78 | $17,940 | $9,780 | 54.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 27 | 131 | $16,375 | $8,164 | 49.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 33 | 53 | $18,020 | $7,078 | 39.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 35 | 57 | $10,032 | $5,125 | 51.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 19 | 35 | $6,125 | $3,282 | 53.6% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2023 | 21 | 21 | $4,975 | $2,747 | 55.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 22 | 30 | $4,050 | $1,781 | 44.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 99 | 200 | $3,000 | $1,672 | 55.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 44 | 45 | $1,800 | $1,321 | 73.4% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 16 | 16 | $1,360 | $1,213 | 89.2% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2023 | 32 | 32 | $1,600 | $1,072 | 67.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 33 | 35 | $1,400 | $1,028 | 73.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 106 | 287 | $52,367 | $23,293 | 44.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 35 | 200 | $25,000 | $11,211 | 44.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 84 | 84 | $18,440 | $10,750 | 58.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 37 | 53 | $18,020 | $7,636 | 42.4% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 36 | 52 | $9,152 | $4,309 | 47.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 15 | 26 | $4,550 | $2,107 | 46.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 20 | 24 | $3,120 | $1,496 | 48.0% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 19 | 19 | $1,535 | $1,335 | 87.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 38 | 38 | $1,520 | $1,063 | 70.0% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2022 | 21 | 21 | $1,015 | $660.85 | 65.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 99 | 209 | $3,135 | $618.57 | 19.7% |
| 81002 | Urinalysis, manual test | Office | 2022 | 12 | 24 | $310.00 | $82.58 | 26.6% |
About Dr. Manish Sachdeva, MD
Dr. Manish Sachdeva, MD is a Internal Medicine healthcare provider based in Hamilton, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1649223074.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Manish Sachdeva, MD has received a total of $7,170 in payments from pharmaceutical and medical device companies, with $1,324 received in 2024. These payments were reported across 453 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($7,167).
As a Medicare-enrolled provider, Sachdeva has provided services to 2,453 Medicare beneficiaries, totaling 4,790 services with total Medicare billing of $295,058. Data is available for 4 years (2020–2023), covering 51 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Hamilton, OH
- Active Since 05/18/2006
- Last Updated 04/10/2015
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1649223074
Products in Payments
- FARXIGA (Drug) $977.61
- XARELTO (Drug) $658.18
- Ozempic (Drug) $466.61
- Kerendia (Drug) $407.32
- ENTRESTO (Drug) $363.95
- BREZTRI (Drug) $215.76
- FREESTYLE LIBRE 2 (Device) $202.63
- Vascepa (Drug) $199.56
- Rybelsus (Drug) $199.46
- Cologuard Collection Kit (Device) $188.68
- JARDIANCE (Drug) $183.26
- QUVIVIQ (Drug) $180.85
- AIRSUPRA (Drug) $178.48
- VERQUVO (Drug) $146.53
- ELIQUIS (Drug) $145.78
- SYMBICORT (Drug) $103.14
- NURTEC ODT (Drug) $93.59
- XIFAXAN (Drug) $93.43
- Victoza (Drug) $92.10
- SOLIQUA 100/33 (Biological) $90.69
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Hamilton
Baker Machhadieh, M.d, M.D
Internal Medicine — Payments: $331,588
Sumitha Reddy, Md, MD
Internal Medicine — Payments: $237,170
Peter Scheidler, D.o, D.O
Internal Medicine — Payments: $163,126
Dr. Edward Wingfield, M.d, M.D
Internal Medicine — Payments: $127,545
Mr. Thomas Sargero, Md, MD
Internal Medicine — Payments: $98,525
Dr. Rosalyn Juergens, Md Phd, MD PHD
Internal Medicine — Payments: $39,987